Literature DB >> 19030774

Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Straussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family.

Anna Rita Giovagnoli1, Giuseppe Di Fede, Anna Aresi, Fabiola Reati, Giacomina Rossi, Fabrizio Tagliavini.   

Abstract

OBJECTIVE: To describe a new dementia phenotype of Gerstmann-Straussler-Scheinker disease (GSS) in a previously unreported Italian family. Design Longitudinal clinical and neuropsychological assessment, combined with magnetic resonance imaging (MRI), single positron emission tomography (SPECT) and molecular genetic studies. Setting Neuropsychology Laboratory, and Division of Neuropathology and Neurology, "C. Besta" National Neurological Institute. Patients and participants Three members of the family. Measurements and results. Standardised neuropsychological tests were used to determine cognitive patterns. The proband had a history of primary dementia characterised by loss of initiative, planning, behaviour control, awareness, language and memory; the two relatives suffered from progressive ataxia. MRI of the demented patient revealed brain atrophy with a hyperintense signal in the frontal cortex; SPECT revealed decreased perfusion in the left temporal and parietal cortex and left thalamus. The two ataxic patients showed cerebellar atrophy with no signs of altered perfusion. Analysis of the PRNP gene showed a proline/leucine substitution at codon 102 in all three patients, associated with methionine/valine heterozygosity at the polymorphic codon 129. Conclusions Primary dementia with prominent frontotemporal signs is a new phenotypical expression of P102L-related GSS that coexists in the same family with the ataxic form of the disease. This remarkable variability suggests that still unidentified genetic or acquired factors may modulate the manifestations of GSS. Genetic examination of the PRNP should be included in the diagnostic work-up of patients with poorly classifiable dementia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030774     DOI: 10.1007/s10072-008-1025-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  23 in total

1.  Raven's coloured progressive matrices: normative values on 305 adult normal controls.

Authors:  A Basso; E Capitani; M Laiacona
Journal:  Funct Neurol       Date:  1987 Apr-Jun

2.  Memory in patients with cerebellar degeneration.

Authors:  I M Appollonio; J Grafman; V Schwartz; S Massaquoi; M Hallett
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

3.  An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques.

Authors:  T Kitamoto; R Iizuka; J Tateishi
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

4.  Imitating gestures. A quantitative approach to ideomotor apraxia.

Authors:  E De Renzi; F Motti; P Nichelli
Journal:  Arch Neurol       Date:  1980-01

5.  Mutations of the prion protein gene phenotypic spectrum.

Authors:  Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

Review 6.  Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies.

Authors:  S Collins; C A McLean; C L Masters
Journal:  J Clin Neurosci       Date:  2001-09       Impact factor: 1.961

7.  Gerstmann-Sträussler-Scheinker disease with the Q217R mutation mimicking frontotemporal dementia.

Authors:  John Woulfe; Andrew Kertesz; Inge Frohn; Sharon Bauer; Peter St George-Hyslop; Catherine Bergeron
Journal:  Acta Neuropathol       Date:  2005-07-16       Impact factor: 17.088

8.  Neuropsychological function in patients with Gerstmann-Sträussler-Scheinker disease from the Indiana kindred (F198S).

Authors:  F W Unverzagt; M R Farlow; J Norton; S R Dlouhy; K Young; B Ghetti
Journal:  J Int Neuropsychol Soc       Date:  1997-03       Impact factor: 2.892

9.  Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.

Authors:  Keisuke Ishizawa; Takashi Komori; Tomokazu Shimazu; Toshimasa Yamamoto; Tetsuyuki Kitamoto; Kunio Shimazu; Takanori Hirose
Journal:  Acta Neuropathol       Date:  2002-05-14       Impact factor: 17.088

Review 10.  Gerstmann-Sträussler-Scheinker disease and the Indiana kindred.

Authors:  B Ghetti; S R Dlouhy; G Giaccone; O Bugiani; B Frangione; M R Farlow; F Tagliavini
Journal:  Brain Pathol       Date:  1995-01       Impact factor: 6.508

View more
  7 in total

1.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 2.  Translational Research in Alzheimer's and Prion Diseases.

Authors:  Giuseppe Di Fede; Giorgio Giaccone; Mario Salmona; Fabrizio Tagliavini
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Exploring dementia and neuronal ceroid lipofuscinosis genes in 100 FTD-like patients from 6 towns and rural villages on the Adriatic Sea cost of Apulia.

Authors:  Celeste Sassi; Rosa Capozzo; Monia Hammer; Chiara Zecca; Monica Federoff; Cornelis Blauwendraat; Nick Bernstein; Jinhui Ding; J Raphael Gibbs; Timothy Price; Andrew Singleton; Giancarlo Logroscino
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

4.  Alterations of Striatal Subregions in a Prion Protein Gene V180I Mutation Carrier Presented as Frontotemporal Dementia With Parkinsonism.

Authors:  Zhongyun Chen; Jinghong Ma; Li Liu; Shuying Liu; Jing Zhang; Min Chu; Zhen Wang; Piu Chan; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2022-04-15       Impact factor: 5.702

5.  An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.

Authors:  Keisuke Ishizawa; Takashi Mitsufuji; Kei Shioda; Atsushi Kobayashi; Takashi Komori; Yoshihiko Nakazato; Tetsuyuki Kitamoto; Nobuo Araki; Toshimasa Yamamoto; Atsushi Sasaki
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

6.  Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.

Authors:  Giuseppe Di Fede; Marcella Catania; Cristiana Atzori; Fabio Moda; Claudio Pasquali; Antonio Indaco; Marina Grisoli; Marta Zuffi; Maria Cristina Guaita; Roberto Testi; Stefano Taraglio; Maria Sessa; Graziano Gusmaroli; Mariacarmela Spinelli; Giulia Salzano; Giuseppe Legname; Roberto Tarletti; Laura Godi; Maurizio Pocchiari; Fabrizio Tagliavini; Daniele Imperiale; Giorgio Giaccone
Journal:  Acta Neuropathol Commun       Date:  2019-01-03       Impact factor: 7.801

Review 7.  Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction.

Authors:  Hajar Miranzadeh Mahabadi; Changiz Taghibiglou
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.